Review of Chinese medicine as adjunct therapy for the bladder urothelial carcinoma

VernacularTitle: 中医药辅助治疗膀胱尿路上皮癌研究进展
Author: Lin ZHANG ¹ ; Jianwu SHEN ; Fanxiong ZENG ; Kuiqing SHAO ; Qi LI ; Ding LI ; Yujing LI ; Zhan GAO
Author Information

1. Master of Grade 2015, Graduate School of China Academy of Chinese Medical Sciences, Beijing 100700, China
Publication Type:Journal Article
Keywords: Bladder transitional cell carcinoma; Antineoplastic drugs (TCD); Neoadjuvant therapy; Review
From: International Journal of Traditional Chinese Medicine 2018;40(8):788-790,f3
CountryChina
Language:Chinese
Abstract: This article collects related literatures which is about the Chinese medicine adjuvant treatment of bladder urothelial carcinoma, and sums up the etiology, pathogenesis and TCM auxiliary treatment methods of this disease. Through the analysis, it is believed that the pathogeny of the disease is mainly concentrated in the aspects of damp, heat, blood stasis and poison. The literature on the adjuvant treatment of bladder urothelial carcinoma mainly focuses on the treatment of syndrome differentiation, postoperative recovery, postoperative perfusion, adjuvant chemotherapy and palliative therapy. The progress of its research is summarized as follows.